Trials / Withdrawn
WithdrawnNCT05530889
Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular Allergies
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This will be a prospective, randomized, bilateral eye, crossover, non-masked single site pilot study to compare the severity of symptoms of itching between test and control lens after two weeks of wear.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TEST Lens | ACUVUE® Theravision® with Ketotifen |
| DEVICE | CONTROL Lens | 1-DAY ACUVUE® MOIST. |
Timeline
- Start date
- 2024-01-15
- Primary completion
- 2024-05-13
- Completion
- 2024-05-13
- First posted
- 2022-09-07
- Last updated
- 2024-02-01
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05530889. Inclusion in this directory is not an endorsement.